Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The remission phase in type 1 diabetes: Changing epidemiology, definitions, and emerging immuno‐metabolic mechanisms
Ting Zhong, Rong Tang, Siyuan Gong, et al.
Diabetes/Metabolism Research and Reviews (2019) Vol. 36, Iss. 2
Closed Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Type 1 and type 2 diabetes mortality burden: Predictions for 2030 based on Bayesian age‐period‐cohort analysis of China and global mortality burden from 1990 to 2019
Chunping Dong, Guifu Wu, Hui Li, et al.
Journal of Diabetes Investigation (2024) Vol. 15, Iss. 5, pp. 623-633
Open Access | Times Cited: 11
Telemedicine in improving glycemic control among children and adolescents with type 1 diabetes mellitus: A systematic review and meta-analysis (Preprint)
Kun Zhang, Qiyuan Huang, Qiaosong Wang, et al.
Journal of Medical Internet Research (2024) Vol. 26, pp. e51538-e51538
Open Access | Times Cited: 8
Adult-onset autoimmune diabetes
Raffaella Buzzetti, Ernesto Maddaloni, Jason L. Gaglia, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 34
Residual insulin secretion in individuals with type 1 diabetes in Finland: longitudinal and cross-sectional analyses
Minna Harsunen, Jani K. Haukka, Valma Harjutsalo, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 7, pp. 465-473
Closed Access | Times Cited: 16
Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination
Berna İmge Aydoğan, Uğur Ünlütürk, Mustafa Cesur
Endocrine (2022) Vol. 78, Iss. 1, pp. 42-46
Open Access | Times Cited: 25
Mechanisms and therapeutic strategies of immune checkpoint molecules and regulators in type 1 diabetes
Jiatong Ding, Kangping Yang, Kong-Lan Lin, et al.
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 13
Impact of the initiation of isCGM soon after type 1 diabetes mellitus diagnosis in adults on glycemic indices and fear of hypoglycemia: a randomized controlled trial
Jerzy Hohendorff, Agata Grzelka-Wozniak, Marta Wróbel, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Enhancing diabetes self-management through the AADE7 self-care behaviors framework: an observational study
Denise Machado Mourão, Gean Moreira Silva Santos, Glaucia Cruzes Duarte
Einstein (São Paulo) (2025) Vol. 23
Open Access
Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”
Dmitry S. Karpov, Anastasiia O. Sosnovtseva, S. V. Pylina, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17320-17320
Open Access | Times Cited: 11
PD-1 and PD-L1 Expression in Peripheral CD4/CD8+ T Cells Is Restored in the Partial Remission Phase in Type 1 Diabetes
Xia Li, Ting Zhong, Rong Tang, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 6, pp. 1947-1956
Open Access | Times Cited: 27
Association between sitagliptin plus vitamin D3 (VIDPP-4i) use and clinical remission in patients with new-onset type 1 diabetes: a retrospective case-control study
Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, Marcelo Müller de Arruda, et al.
Archives of Endocrinology and Metabolism (2023) Vol. 67, Iss. 5
Open Access | Times Cited: 10
Gene expression signature predicts rate of type 1 diabetes progression
Tomi Suomi, Inna Starskaia, Ubaid Ullah Kalim, et al.
EBioMedicine (2023) Vol. 92, pp. 104625-104625
Open Access | Times Cited: 9
Spontaneous remission and relapse of diabetes mellitus in a male dog
Mariola B. Rak, Chen Gilor, Stijn Niessen, et al.
Journal of Veterinary Internal Medicine (2024) Vol. 38, Iss. 2, pp. 1152-1156
Open Access | Times Cited: 3
Risk factors for type 1 diabetes, including environmental, behavioural and gut microbial factors: a case–control study
Deborah Traversi, Ivana Rabbone, Giacomo Scaioli, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 25
Beta Cell Therapies for Preventing Type 1 Diabetes: From Bench to Bedside
Gabriel Brawerman, Peter J. Thompson
Biomolecules (2020) Vol. 10, Iss. 12, pp. 1681-1681
Open Access | Times Cited: 22
Frequency, clinical characteristics, and determinants of partial remission in type 1 diabetes: Different patterns in children and adults
Ting Zhong, Rong Tang, Yuting Xie, et al.
Journal of Diabetes (2020) Vol. 12, Iss. 10, pp. 761-768
Closed Access | Times Cited: 21
C-peptide and residual β-cell function in pediatric diabetes – state of the art
Milena Jamiołkowska, Barbara Głowińska‐Olszewska, Artur Bossowski
Pediatric Endocrinology Diabetes and Metabolism (2021) Vol. 27, Iss. 2, pp. 123-133
Open Access | Times Cited: 18
The Remission Phase in Type 1 Diabetes: Role of Hyperglycemia Rectification in Immune Modulation
Rong Tang, Ting Zhong, Chao Wu, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 21
What’s in a Name? Redefining Type 2 Diabetes Remission
Sanjay Kalra, Arbinder Singal, Tejal Lathia
Diabetes Therapy (2021) Vol. 12, Iss. 3, pp. 647-654
Open Access | Times Cited: 17
Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes
Laia Gómez-Muñoz, David Perna‐Barrull, Josep M. Caroz-Armayones, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Differences in insulin sensitivity in the partial remission phase of childhood type 1 diabetes; a longitudinal cohort study
Freja B. Mørk, Jens Otto Broby Madsen, Andreas Kryger Jensen, et al.
Diabetic Medicine (2021) Vol. 39, Iss. 2
Closed Access | Times Cited: 14
The remission phase in adolescents and young adults with newly diagnosed type 1 diabetes mellitus: prevalence, predicting factors and glycemic control during follow-up
Mériem Yazidi, Sana Mahjoubi, Ibtissem Oueslati, et al.
Archives of Endocrinology and Metabolism (2022)
Open Access | Times Cited: 9
The Association of Autoimmune Diseases with Type 1 Diabetes Mellitus in Children Depends Also by the Length of Partial Clinical Remission Phase (Honeymoon)
Gülsüm Özen, Angela Zanfardino, Santino Confetto, et al.
International Journal of Endocrinology (2020) Vol. 2020, pp. 1-5
Open Access | Times Cited: 13
Approaches to Measuring Beta Cell Reserve and Defining Partial Clinical Remission in Paediatric Type 1 Diabetes
Elaine Kennedy, Colin P. Hawkes
Children (2024) Vol. 11, Iss. 2, pp. 186-186
Open Access | Times Cited: 1
A Quick Look at the Present and Immediate Future of Type 1 DM
Ignacio Díez López, Sandra Maeso Méndez
(2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top